Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Neurovascular Coupling in Eyes of Glaucoma Patients
This clinical trial update reports the completion of a study on neurovascular coupling in the eyes of glaucoma patients, including individua…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial assessing safety and efficacy of ALPHAGAN P and LUMIGAN in patients previously treated with latanoprost for glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 studies evaluating the safety and efficacy of liposomal latanoprost for ocular hypertension have completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 study comparing AGN-210669 ophthalmic solution with bimatoprost ophthalmic solution in open-angle glaucoma or ocular hypertension; r…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Ocular Hypertension Treatment Study (OHTS)
Clinical trial update indicating the Ocular Hypertension Treatment Study (OHTS) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C [Phase 2]
A Phase 2 trial evaluating AL-59412C in open-angle glaucoma and ocular hypertension reported safety data and intraocular pressure-lowering e…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Travoprost 3-Month Safety and Efficacy Study [Phase 3]
Phase 3 trial evaluating Travoprost for safety and efficacy in open-angle glaucoma and ocular hypertension has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]
This clinical trial update reports on the safety and efficacy of AGN 210669 Ophthalmic Solution in patients with ocular hypertension or prim…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution [Phase 2]
A Phase 2 trial comparing three formulations of AGN-210669 ophthalmic solution against Bimatoprost ophthalmic solution for glaucoma (open-an…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
This document reports the completion of a Phase 2 dose-evaluation study of the latanoprost punctal plug delivery system (L-PPDS) in subjects…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 dose-evaluation trial assessing the effect of punctal plug placement on the efficacy and safety of the Latanoprost punctal plug deli…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Study of LUMIGAN® RC in the Clinical Setting [Phase 4]
Phase 4 clinical trial update for LUMIGAN RC in glaucoma and ocular hypertension; the study has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
This clinical trial update reports the completion and posting of results for an observational study evaluating Lumigan (bimatoprost) 0.01% f…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 study evaluating the Latanoprost punctal plug delivery system (L-PPDS) for ocular hypertension or open-angle glaucoma has completed;…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG [Phase 2]
A completed Phase 2 clinical trial evaluating different formulations of L-PPDS in subjects with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial evaluating the safety and efficacy of the Punctum Plug Delivery System in Open-angle glaucoma or ocular hypertension has been …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial results evaluating the safety and efficacy of a triple combination therapy in patients with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) [Phase 2]
A Phase 2 study evaluating latanoprost delivered via a punctal plug system (L-PPDS) for open-angle glaucoma and ocular hypertension has comp…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma [Phase 2]
A Phase 2 safety study evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with ocular hypertension or open-angle g…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 study evaluating whether artificial tears affect the response to a latanoprost punctal plug delivery system in adults with glaucoma …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
Clinical trial update from Allergan indicating a completed study comparing quantitative assessments in open-angle glaucoma and ocular hypert…
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
A Phase 2 trial evaluating a latanoprost punctal plug delivery system for ocular hypertension or open-angle glaucoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) [Phase 4]
Phase 4 study comparing intraocular pressure control in open-angle glaucoma or ocular hypertension patients treated with travoprost 0.004% v…
-
FDA approval · 2013-08-28FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Tafluprost Ophthalmic submitted by Prasco Laboratories. Tafluprost ophthalmic is used to low…
-
FDA approval · 2013-07-22FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lumigan (bimatoprost) filed by Allergan, resulting in changes to labeling or indication.